← FDA Drug Approvals (Drugs@FDA)
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK SPECLT · Approved 2015-10-30
Drug application
- FDA Application #
ANDA202894- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
- Generic name
- CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
- Active ingredients
- BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
- Dosage form
- CREAM
- Route
- TOPICAL
- Marketing status
- Discontinued
- Sponsor
- GLENMARK SPECLT
- Manufacturer
- Glenmark Pharmaceuticals Inc. USA
- First approval
- 2015-10-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown